The future of health, according to TurtleTree, involves precision fermentation to create vegan alternatives to key nutritional components. The company, which is pioneering the world’s first vegan lactoferrin, LF+, has now closed a $1.0M Series A funding round.
Lactoferrin, a bioactive milk protein, is typically sourced from animals but is used to enhance the nutritional profile of a wide range of food and health products, from plant-based alternatives to skincare and cosmetics. TurtleTree's innovative process aims to provide these benefits while ensuring animal welfare.
.png&w=3840&q=75)
